Piperazine (Padax Blackcurrant Flavour, Padax Orange Flavour, Padax)
Piperazine
Adcock ingram limited
Every registration of this product has been cancelled.
Registration
- Applicant
- Adcock ingram limited
- Registrations
- 4
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Padax syrup - blackcurrant flavour EACH 5,0 ml SYRUP CONTAINS PIPERAZINE CITRATE 850,0 mg | -Syrup | 33049033/12/0490 | Cancelled | Not determined | None |
| Padax syrup - orange flavour EACH 5,0 ml SYRUP CONTAINS PIPERAZINE CITRATE 850,0 mg | -Syrup | 33049133/12/0491 | Cancelled | Not determined | None |
| Padax granules EACH SACHET CONTAINS PIPERAZINE CITRATE 1,650 g | Granules | C0224C/12/224 | Cancelled | Not determined | None |
| Padax syrup EACH 5 ml SYRUP CONTAINS PIPERAZINE CITRATE A 850 mg | Syrup | H0873 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.